INSIGHTS
Cardiometabolic Africa
From disease burden to market-access pathways
Francophone Africa is not one market and cardiometabolic care is not one product category.
At Med Gateway International LLC, we approach cardiometabolic market access through the full patient pathway: risk identification, screening, diagnostics, treatment initiation, monitoring, complication management and continuity of care.
Our objective is to identify where the pathway breaks, why it breaks, and where healthcare technologies, diagnostics, medical devices and supply-chain solutions can create measurable value.
The cardiometabolic landscape in Africa represents both the most significant public health challenge and the most substantial healthcare market opportunity of the coming decade.
24.6M
Adults living with diabetes (IDF Africa Region, 2024; projected 59.5M by 2050, 142% increase).
72.6%
Diabetes remains undiagnosed (IDF Africa Region estimate).
~12%
Hypertension controlled (WHO African Region; fewer than one-third treated, ~12% controlled).
1.6M
Premature NCD deaths annually (WHO African Region; 30–70 years, four major NCD groups, CVD leading cause).
Data note: Regional estimates are used to illustrate broader cardiometabolic trends. WHO African Region and IDF Africa Region definitions are not identical. Med Gateway conducts country-specific market intelligence before drawing commercial conclusions for individual Francophone African markets.
Our View
The opportunity is not simply “more products”
Isolated products in fragmented systems are insufficient; we emphasize deep pathway understanding first to ensure sustainable market access and clinical impact.
The Cardiometabolic Pathway We Analyze
01
Risk Identification & Screening
Early detection systems for at-risk populations.
02
Diagnostics & Risk Stratification
Advanced diagnostic precision and patient grouping.
03
Treatment Access
Streamlined pathways for therapeutic initiation.
04
Monitoring & Continuity
Ongoing care management and patient adherence.
05
Complication Management
Advanced care for chronic cardiometabolic outcomes.
Our Francophone Africa Market-Access Framework
Patient Pathway
Commercial Pathway
Market Intelligence
Strategic Sourcing
Stakeholder Mapping
Commercial Coordination
Access Gaps
From Market Intelligence to Market Access
Healthcare Need
Patient Pathway Mapping
Weak-Link Identification
Market & Stakeholder Intelligence
Solution / Product Fit
Regulatory & Procurement Pathway
Distributor / Commercial Partner Mapping
Market Entry & Commercial Coordination
Monitoring of Market Development
Cardiometabolic Market Access Francophone Africa
Med Gateway International LLC